UROMED CORP
10-Q, EX-27, 2000-08-14
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: UROMED CORP, 10-Q, 2000-08-14
Next: GUILFORD PHARMACEUTICALS INC, 10-Q, 2000-08-14



<TABLE> <S> <C>


      <ARTICLE>           5
      <LEGEND>
      THIS SCHEDULE  CONTAINS  SUMMARY  FINANCIAL  INFORMATION  FROM THE BALANCE
      SHEET  AND THE  STATEMENT  OF  OPERATIONS  FILED AS PART OF THE  QUARTERLY
      REPORT ON FORM 10Q AND IS  QUALIFIED  IN ITS ENTIRETY BY REFERENCE TO SUCH
      QUARTERLY REPORT ON FROM 10Q.
      </LEGEND>
      <CIK>                         0000917821
      <NAME>                            UroMed-Corp.
      <MULTIPLIER>                      1,000

      <S>                           <C>
      <PERIOD-TYPE>                 6-MOS
      <FISCAL-YEAR-END>                                              DEC-31-2000
      <PERIOD-START>                                                 JAN-01-2000
      <PERIOD-END>                                                   JUN-30-2000
      <CASH>                                                               5,157
      <SECURITIES>                                                         7,399
      <RECEIVABLES>                                                          902
      <ALLOWANCES>                                                            76
      <INVENTORY>                                                          1,202
      <CURRENT-ASSETS>                                                    15,692
      <PP&E>                                                               1,542
      <DEPRECIATION>                                                       1,446
      <TOTAL-ASSETS>                                                      17,583
      <CURRENT-LIABILITIES>                                                1,041
      <BONDS>                                                             14,393
                                                          0
                                                                    0
      <COMMON>                                                           107,258
      <OTHER-SE>                                                       (105,109)
      <TOTAL-LIABILITY-AND-EQUITY>                                        17,583
      <SALES>                                                              2,235
      <TOTAL-REVENUES>                                                     2,235
      <CGS>                                                                1,758
      <TOTAL-COSTS>                                                        4,349
      <OTHER-EXPENSES>                                                         0
      <LOSS-PROVISION>                                                         0
      <INTEREST-EXPENSE>                                                   (520)
      <INCOME-PRETAX>                                                    (2,182)
      <INCOME-TAX>                                                             0
      <INCOME-CONTINUING>                                                (2,182)
      <DISCONTINUED>                                                           0
      <EXTRAORDINARY>                                                      1,259
      <CHANGES>                                                                0
      <NET-INCOME>                                                         (923)
      <EPS-BASIC>                                                       (0.17)
      <EPS-DILUTED>                                                       (0.17)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission